Alison J. Holmes

7.7k total citations · 1 hit paper
16 papers, 5.4k citations indexed

About

Alison J. Holmes is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Alison J. Holmes has authored 16 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Alison J. Holmes's work include Lung Cancer Treatments and Mutations (8 papers), Colorectal Cancer Treatments and Studies (3 papers) and Lung Cancer Research Studies (3 papers). Alison J. Holmes is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Colorectal Cancer Treatments and Studies (3 papers) and Lung Cancer Research Studies (3 papers). Alison J. Holmes collaborates with scholars based in United States, United Kingdom and Italy. Alison J. Holmes's co-authors include Pasi A. Jänne, Bruce E. Johnson, Neal I. Lindeman, Federico Cappuzzo, Jeffrey A. Engelman, Xiao‐Jun Zhao, James G. Christensen, Charles Lee, Youngchul Song and Tetsuya Mitsudomi and has published in prestigious journals such as Science, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Alison J. Holmes

16 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling

2007 3.6k citations Jeffrey A. Engelman, Kreshnik Zejnullahu et al. Science profile →

Peers

Countries citing papers authored by Alison J. Holmes

Since Specialization

Citations

This map shows the geographic impact of Alison J. Holmes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison J. Holmes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison J. Holmes more than expected).

Fields of papers citing papers by Alison J. Holmes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison J. Holmes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison J. Holmes. The network helps show where Alison J. Holmes may publish in the future.

Co-authorship network of co-authors of Alison J. Holmes

This figure shows the co-authorship network connecting the top 25 collaborators of Alison J. Holmes. A scholar is included among the top collaborators of Alison J. Holmes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison J. Holmes. Alison J. Holmes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	A non-biological option for Se removal by photocatalytic reduction of selenate in mine-impacted water containing high concentrations of sulfate and nitrate 2020 ·Open Collections ·Alison J. Holmes, (unknown), (unknown), (unknown), A.H.W. Ngan, Frank Gu	1
2	Ultra deep sequencing detects a low rate of mosaic mutations in tuberous sclerosis complex 2010 ·Human Genetics ·Wei Qin, Piotr Kozłowski, Bruce E. Taillon, Pascal Bouffard, Alison J. Holmes, Pasi A. Jänne, Susana Camposano, Elizabeth A. Thiele, David Neal Franz, David J. Kwiatkowski	70
3	Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patients 2008 ·British Journal of Cancer ·Federico Cappuzzo, Marileila Varella‐Garcia, Giovanna Finocchiaro, Margaret C. Skokan, Sujatha Gajapathy, Carlo Carnaghi, Lorenza Rimassa, Elisa Rossi, C. Ligorio, Luca Di Tommaso, Alison J. Holmes, Luca Toschi, Giovanni Tallini, Annarita Destro, Massimo Roncalli, Armando Santoro, Pasi A. Jänne	145
4	Are There Any Ethnic Differences in Molecular Predictors of Erlotinib Efficacy in Advanced Non-Small Cell Lung Cancer? 2008 ·Clinical Cancer Research ·Myung‐Ju Ahn, Byeong-Bae Park, Jin Seok Ahn, (unknown), Heung‐Tae Kim, (unknown), Jin‐Hyoung Kang, Y. Choi, Hong Song, Se Hoon Park, (unknown), Sang Won Shin, (unknown), Chang‐Seok Ki, (unknown), Alison J. Holmes, Pasi A. Jänne, Keunchil Park	47
5	Comparison of genotyping with direct sequencing as a method to detect EGFR mutations in NSCLC 2008 ·Journal of Clinical Oncology ·Alison J. Holmes, Victoria A. Joshi, Yanan Kuang, Andrew M. Rogers, Pasi A. Jänne	2
6	MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling breakdown → 2007 ·Science ·Jeffrey A. Engelman, Kreshnik Zejnullahu, Tetsuya Mitsudomi, Youngchul Song, Courtney Hyland, Joon Oh Park, Neal I. Lindeman, (unknown), Xiao‐Jun Zhao, James G. Christensen, Takayuki Kosaka, Alison J. Holmes, Andrew M. Rogers, Federico Cappuzzo, Tony Mok, Charles Lee, Bruce E. Johnson, Lewis C. Cantley, Pasi A. Jänne	3570
7	Prospective Study of Gefitinib in Epidermal Growth Factor Receptor Fluorescence In Situ Hybridization–Positive/Phospho-Akt–Positive or Never Smoker Patients With Advanced Non–Small-Cell Lung Cancer: The ONCOBELL Trial 2007 ·Journal of Clinical Oncology ·Federico Cappuzzo, Claudia Ligorio, Pasi A. Jänne, Luca Toschi, Elisa Rossi, Rocco Trisolini, Daniela Paioli, Alison J. Holmes, Elisabetta Magrini, Giovanna Finocchiaro, Stefania Bartolini, Alessandra Cancellieri, Fortunato Ciardiello, Marco Patelli, Lucio Crinò, Marileila Varella‐Garcia	174
8	Phase II Clinical Trial of Chemotherapy-Naïve Patients ≥ 70 Years of Age Treated With Erlotinib for Advanced Non–Small-Cell Lung Cancer 2007 ·Journal of Clinical Oncology ·David M. Jackman, Beow Y. Yeap, Neal I. Lindeman, Panos Fidias, Michael S. Rabin, Jennifer S. Temel, Arthur T. Skarin, Matthew Meyerson, Alison J. Holmes, Ana M. Borras, Boris Freidlin, Patricia Ostler, Joan Lucca, Thomas J. Lynch, Bruce E. Johnson, Pasi A. Jänne	254
9	Exon 19 Deletion Mutations of Epidermal Growth Factor Receptor Are Associated with Prolonged Survival in Non–Small Cell Lung Cancer Patients Treated with Gefitinib or Erlotinib 2006 ·Clinical Cancer Research ·David M. Jackman, Beow Y. Yeap, Lecia V. Sequist, Neal I. Lindeman, Alison J. Holmes, Victoria A. Joshi, Daphne W. Bell, Mark S. Huberman, Balázs Halmos, Michael S. Rabin, Daniel A. Haber, Thomas J. Lynch, Matthew Meyerson, Bruce E. Johnson, Pasi A. Jänne	491
10	Systematic Review of Antimicrobial Drug Prescribing in Hospitals 2006 ·Emerging infectious diseases ·Peter Davey, Erwin Brown, Lynda Fenelon, Roger Finch, Ian M. Gould, Alison J. Holmes, Craig Ramsay, Eric Taylor, Phil Wiffen, Mark H. Wilcox	7
11	Response and Resistance in a Non–Small-Cell Lung Cancer Patient With an Epidermal Growth Factor Receptor Mutation and Leptomeningeal Metastases Treated With High-Dose Gefitinib 2006 ·Journal of Clinical Oncology ·David M. Jackman, Alison J. Holmes, Neal I. Lindeman, Patrick Y. Wen, Santosh Kesari, Ana M. Borras, Christopher J. Bailey, (unknown), Pasi A. Jänne, Bruce E. Johnson	205
12	Using Imipenem and Cilastatin During Continuous Renal Replacement Therapy 2005 ·Pharmacy World & Science ·(unknown), Bryony Dean Franklin, Stephen J. Brett, Alison J. Holmes	6
13	An Epidemic ofBurkholderia cepaciaTransmitted between Patients with and without Cystic Fibrosis 1999 ·The Journal of Infectious Diseases ·Alison J. Holmes, Rathel Nolan, Rebecca F. Taylor, Richard W. Finley, Margaret A. Riley, Ruzhang Jiang, Suzanne Steinbach, Richard Goldstein	109
14	Agricultural Use of Burkholderia (Pseudomonas) cepacia: A Threat to Human Health? 1998 ·Emerging infectious diseases ·Alison J. Holmes, John R. W. Govan, Richard Goldstein	138
15	The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain 1995 ·Nature Medicine ·Li Sun, Ruzhang Jiang, Suzanne Steinbach, Alison J. Holmes, (unknown), J. Forstner, Uma S. Sajjan, Ying Tan, Margaret A. Riley, Richard Goldstein	164
16	Studies on the associations between natural infection of hens, cocks and their progeny with lymphoid leukosis virus 1979 ·Avian Pathology ·L. N. Payne, Alison J. Holmes, K. Howes, M. Pattison, D.E. Walters	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact